LADENBURG THALMANN FINANCIAL SERVICES INC. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 83 filers reported holding REVANCE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 1.4%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$14,000866
+1155.1%
0.00%
Q3 2019$069
+97.1%
0.00%
Q2 2019$0
-100.0%
350.0%0.00%
Q1 2019$1,0000.0%350.0%0.00%
Q4 2018$1,0000.0%350.0%0.00%
Q3 2018$1,00035
+191.7%
0.00%
Q2 2016$0120.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$121,230,00021.92%
Rhenman & Partners Asset Management AB 220,000$5,808,0000.83%
ArrowMark Colorado Holdings LLC 2,045,862$54,011,0000.67%
Vivo Capital, LLC 77,373$2,043,0000.52%
Ghost Tree Capital, LLC 89,295$2,357,0000.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 124,932$3,298,0000.47%
Polar Capital LLP 1,296,371$34,220,0000.46%
SUFFOLK CAPITAL MANAGEMENT LLC 70,095$1,851,0000.24%
EAM Investors, LLC 33,897$895,0000.15%
PointState Capital LP 438,200$11,568,0000.13%
View complete list of REVANCE THERAPEUTICS INC shareholders